
Konstantinos Apostolou, R&D senior manager, Adragos Athens discusses the HPAPI sector and how it’s one of the fastest-growing areas in pharma.
The highly potent active pharmaceutical ingredient (HPAPI) sector is one of the fastest-growing areas in the pharmaceutical industry, fuelled by the need to meet the growing demand for novel targeted treatments.
The high-potency drug market size was valued at $185.5 billion in 2024 and is predicted to reach $520 billion by the year 2034, with more than a quarter of drugs on the market today being classed as highly potent.
HPAPI-based drugs…